Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-19

Clinical Trial Update: An Exploratory Study of PQ Grass 27600 SU [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 exploratory trial update for PQ Grass 27600 SU in seasonal allergic rhinitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PQ Grass 27600 SU

Snippet

Sponsor: Allergy Therapeutics | Conditions: Rhinitis, Allergic, Seasonal | Phase 2, Phase 3 | Status: COMPLETED